Skip to content

Evaluating an online cognitive behaviour therapy program with different levels of support for recent cancer survivors

A randomized non-inferiority trial of technician-assisted and self-guided transdiagnostic Internet-delivered cognitive behaviour therapy for cancer survivors: making treatment scalable

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN32477700
Enrollment
94
Registered
2016-06-24
Start date
2016-07-15
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression and anxiety in cancer survivors Mental and Behavioural Disorders Depression and anxiety in cancer survivors

Interventions

Participants are randomised to one of two groups, who each receive the same internet-based cognitive behavioural therapy (ICPT). The intervention is titled Wellbeing After Cancer. It is based on the W

Sponsors

University of Regina
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Resident of Canada and will be in Canada during the 8 week course period 2. 18 years of age or older 3. Experiencing symptoms of depression and/or anxiety (=8 on the PHQ-9 or GAD-7) 4. Diagnosed with cancer in the past 5 years and have completed active treatment (radiation, chemotherapy, or surgery) 5. Has access to a computer and the Internet 6. Willing to provide a medical contact (e.g., family physician) for an emergency contact

Exclusion criteria

Exclusion criteria: 1. Currently receiving regular psychotherapy for depression or anxiety elsewhere or in some other form 2. Started a new psychotropic medication for anxiety or depression or had a change in dosage within the past month 3. Using illicit drugs or three or more standard drinks/day 4. Current self-reported psychotic disorder or bipolar disorder or severe symptoms of depression (total score > 22 or a score > 2 on question 9 of the PHQ-9, or specific plan/intent of suicide

Design outcomes

Primary

MeasureTime frame
1. Depressive symptoms are measured using the Patient Health Questionnaire- 9 Item (PHQ-9) pre-treatment, before each lesson, immediately following completion of the program, and 1 month following completion of the program 2. Symptoms of generalized anxiety are measured using the Generalized Anxiety Disorder -7 Item (GAD-7) pre-treatment, before each lesson, immediately following completion of the program, and 1 month following completion of the program

Secondary

MeasureTime frame
1. Fear of cancer recurrence is measured using the Fear of Cancer Recurrence Inventory (FCRI-SF) pre-treatment, immediately following completion of the program, and 1 month following completion of the program 2. A secondary measure of anxiety and depressive symptoms will be measured using the Depression and Anxiety Stress Scales (DASS-21) pre-treatment, immediately following completion of the program, and 1 month following completion of the program 3. Quality of life will be measured using the 12-Item Short Form Health Survey (SF-12) pre-treatment, immediately following completion of the program, and 1 month following completion of the program 4. Participant satisfaction with treatment will be measured using satisfaction questions immediately following completion of the program 5. Participants satisfaction with level of support will be assessed using satisfaction questions immediately following completion of the program 6. Number of log-ins are measured immediately following completion of the program 7. Days accessing service are measured immediately following completion of the program 8. Number of emails sent to technician (if applicable) are measured immediately following completion of the program 9. Number of emails received from technician (if applicable) are measured pimmediately following completion of the program 10. Number of phone calls are measured immediately following completion of the program 11. Number of lessons completed are measured immediately following completion of the program

Countries

Canada

Contacts

Public ContactDale Dirkse
dirkse2d@uregina.ca+1 306 337 2598

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026